Skip to content

Home Search Authors Pakistan News Saved

SciRah

SciRah does not host or store research papers. Results come live from free, official scholarly APIs, and every paper links back to its original source.

Data sources

OpenAlex
Semantic Scholar
Crossref
CORE
arXiv
PubMed

Privacy policy Terms of service

G. Verset · SciRah

Researcher profile · Semantic Scholar

G. Verset

Share profile

G. Verset — researcher profile on SciRah

h-index: 19
Works: 60
Citations: 4,055

Most-cited papers

Pembrolizumab in patients with advanced hepatocellular carcinoma previously treated with sorafenib (KEYNOTE-224): a non-randomised, open-label phase 2 trial.
A. Zhu, R. Finn, J. Edeline, S. Cattan +55 more
2018The Lancet Oncology2,090 citations
Semantic Scholar
Cabozantinib plus atezolizumab versus sorafenib for advanced hepatocellular carcinoma (COSMIC-312): a multicentre, open-label, randomised, phase 3 trial.
R. Kelley, L. Rimassa, A. Cheng, A. Kaseb +18 more
2022The Lancet Oncology421 citations Open access
Semantic Scholar
Nivolumab plus ipilimumab versus lenvatinib or sorafenib as first-line treatment for unresectable hepatocellular carcinoma (CheckMate 9DW): an open-label, randomised, phase 3 trial.
T. Yau, P. Galle, T. Decaens, B. Sangro +24 more
2025The Lancet306 citations Open access
Semantic Scholar
Long-term clinical outcome after endoscopic pancreatic ductal drainage for patients with painful chronic pancreatitis.
M. Delhaye, M. Arvanitakis, G. Verset, M. Cremer +1 more
2004Clinical Gastroenterology and Hepatology183 citations
Semantic Scholar
Short course chemotherapy followed by concomitant chemoradiotherapy and surgery in locally advanced rectal cancer: a randomized multicentric phase II study.
R. Maréchal, B. Vos, M. Polus, T. Delaunoit +9 more
2012Annals of Oncology164 citations Open access
Semantic Scholar
Updated efficacy and safety of KEYNOTE-224: a phase II study of pembrolizumab in patients with advanced hepatocellular carcinoma previously treated with sorafenib.
M. Kudo, R. Finn, J. Edeline, S. Cattan +17 more
2022European Journal of Cancer107 citations Open access
Semantic Scholar
The predictive value of FIB‐4 versus FibroTest, APRI, FibroIndex and Forns index to noninvasively estimate fibrosis in hepatitis C and nonhepatitis C liver diseases
M. Adler, B. Gulbis, C. Moreno, S. Evrard +5 more
2008Hepatology106 citations
Semantic Scholar
Pembrolizumab Monotherapy for Previously Untreated Advanced Hepatocellular Carcinoma: Data from the Open-Label, Phase II KEYNOTE-224 Trial
G. Verset, I. Borbath, M. Karwal, C. Verslype +22 more
2022Clinical Cancer Research83 citations Open access
Semantic Scholar
Cabozantinib plus atezolizumab versus sorafenib for advanced hepatocellular carcinoma (COSMIC-312): final results of a randomised phase 3 study.
T. Yau, A. Kaseb, Ann-Lii Cheng, Shu-Kui Qin +18 more
2024The Lancet Gastroenterology and Hepatology81 citations
Semantic Scholar
VP10-2021: Cabozantinib (C) plus atezolizumab (A) versus sorafenib (S) as first-line systemic treatment for advanced hepatocellular carcinoma (aHCC): Results from the randomized phase III COSMIC-312 trial
R. K. Kelley, T. Yau, A. Cheng, A. Kaseb +15 more
2021Annals of Oncology57 citations Open access
Semantic Scholar
Gastrointestinal polypoid lesions: a poorly known endoscopic feature of portal hypertension
A. Lemmers, S. Evrard, P. Demetter, G. Verset +4 more
2014United European Gastroenterology journal57 citations Open access
Semantic Scholar
Retrospective analysis of the immunogenic effects of intra-arterial locoregional therapies in hepatocellular carcinoma: a rationale for combining selective internal radiation therapy (SIRT) and immunotherapy
L. Craciun, R. De Wind, P. Demetter, V. Lucidi +15 more
2020BMC Cancer55 citations Open access
Semantic Scholar
Efficacy of the combination of long-acting release octreotide and tamoxifen in patients with advanced hepatocellular carcinoma: a randomised multicentre phase III study
G. Verset, C. Verslype, H. Reynaert, I. Borbath +7 more
2007British Journal of Cancer41 citations Open access
Semantic Scholar
KEYNOTE-224: Pembrolizumab in patients with advanced hepatocellular carcinoma previously treated with sorafenib.
A. Zhu, R. Finn, S. Cattan, J. Edeline +16 more
201836 citations
Semantic Scholar
Systemic Treatments with Tyrosine Kinase Inhibitor and Platinum-Based Chemotherapy in Patients with Unresectable or Metastatic Hepatocholangiocarcinoma
E. Gigante, C. Hobeika, B. le Bail, V. Paradis +21 more
2022Liver Cancer29 citations Open access
Semantic Scholar
Retrospective European Multicentric Evaluation of Selective Transarterial Chemoembolisation with and without Balloon-Occlusion in Patients with Hepatocellular Carcinoma: A Propensity Score Matched Analysis
R. Golfieri, M. Bezzi, G. Verset, F. Fucilli +7 more
2021Cardiovascular and Interventional Radiology29 citations Open access
Semantic Scholar
Balloon-Occluded Transarterial Chemoembolization: In Which Size Range Does It Perform Best? A Comparison of Its Efficacy versus Conventional Transarterial Chemoembolization, Using Propensity Score Matching
R. Golfieri, M. Bezzi, G. Verset, F. Fucilli +7 more
2021Liver Cancer26 citations Open access
Semantic Scholar
Phase I clinical trial of decitabine (5-aza-2'-deoxycytidine) administered by hepatic arterial infusion in patients with unresectable liver-predominant metastases
Y. Jansen, G. Verset, K. Schats, Pieter-Jan van Dam +4 more
2019ESMO Open25 citations Open access
Semantic Scholar
DLL4 expression is a prognostic marker and may predict gemcitabine benefit in resected pancreatic cancer
A. Drouillard, F. Puleo, J. Bachet, S. Ouazzani +5 more
2016British Journal of Cancer20 citations Open access
Semantic Scholar
Updated efficacy and safety of KEYNOTE-224: A phase II study of pembrolizumab (pembro) in patients with advanced hepatocellular carcinoma (HCC).
M. Kudo, R. Finn, J. Edeline, S. Cattan +16 more
202019 citations
Semantic Scholar
Real Life Prospective Evaluation of New Drug-Eluting Platform for Chemoembolization of Patients with Hepatocellular Carcinoma: PARIS Registry
T. de Baère, B. Guiu, M. Ronot, P. Chevallier +7 more
2020Cancers15 citations Open access
Semantic Scholar
Long-Term Outcomes of Balloon TACE for HCC: An European Multicentre Single-Arm Retrospective Study
P. Lucatelli, B. Rocco, T. De Beare, G. Verset +8 more
2024Cardiovascular and Interventional Radiology14 citations Open access
Semantic Scholar
Transarterial Chemoembolization with Anthracyclines-Loaded Polyethylene Glycol Drug Eluting Microspheres for the Treatment of Hepatocellular Carcinoma: A Pooled Multicentric Analysis of Survival in 580 Patients
Filipe Veloso Gomes, T. de Baère, G. Verset, É. Coimbra +3 more
2023Cardiovascular and Interventional Radiology12 citations Open access
Semantic Scholar
Pembrolizumab (pembro) in patients with advanced hepatocellular carcinoma (HCC): KEYNOTE-224 update.
A. Zhu, R. Finn, J. Edeline, S. Cattan +16 more
201811 citations
Semantic Scholar
Safety and efficacy of Holmium-166 selective internal radiotherapy of primary and secondary liver cancer confirmed by real-world data
V. Schulze-Zachau, G. Verset, P. de Bondt, Katrien De Keukeleire +9 more
2024Frontiers in Oncology9 citations Open access
Semantic Scholar
In the Era of Systemic Therapy for Hepatocellular Carcinoma Is Transarterial Chemoembolization Still a Card to Play?
Ana-Maria Bucalau, I. Tancredi, G. Verset
2021Cancers8 citations Open access
Semantic Scholar
Fatal hemobilia in advanced hepatocellular carcinoma invading biliary tract after treatment with sorafenib and biliary stenting.
G. Verset, R. Maréchal, Maria Antonietta Bali, J. Devière +1 more
2010Annals of Oncology8 citations Open access
Semantic Scholar
Unusual metastasis in BRCA mutated pancreatic cancer while on maintenance Olaparib: Two case reports and review of the literature.
I. Assaf, L. Mans, R. Sakr, G. Verset +1 more
2021European Journal of Cancer7 citations
Semantic Scholar
Genetics of alcohol-related hepatocellular carcinoma - its role in risk prediction
Ken Liu, G. Verset, E. Trépo, D. Seth
20207 citations Open access
Semantic Scholar
Balloon-occluded chemoembolization for hepatocellular carcinoma: a prospective study of safety, feasibility and outcomes
Ana-Maria Bucalau, I. Tancredi, M. Pezzullo, Raphael Leveque +3 more
2020Hepatic Oncology6 citations Open access
Semantic Scholar
Preoperative gemcitabine-nab-paclitaxel (G-NP) for (borderline) resectable (BLR) or locally advanced (LA) pancreatic ductal adenocarcinoma (PDAC): Feasibility results and early response monitoring by Diffusion-Weighted (DW) MR.
J. Van Laethem, M. Bali, I. Borbath, G. Verset +9 more
20165 citations
Semantic Scholar
Clinical impact of 99mTc-MAA SPECT/CT-based personalized predictive dosimetry in selective internal radiotherapy: a real-life single-center experience in unresectable HCC patients
Ana-Maria Bucalau, Benoît Collette, I. Tancredi, M. Vouche +7 more
2023European Journal of Hybrid Imaging4 citations Open access
Semantic Scholar
Real-life multi-center retrospective analysis on nivolumab in difficult-to-treat patients with advanced hepatocellular carcinoma
N. De Wilde, L. Vonghia, S. Francque, T. De Somer +6 more
2022World Journal of Hepatology4 citations Open access
Semantic Scholar
Comparison of PMT-based TF64 and SiPM-based Vereos PET/CT systems for 90 Y imaging and dosimetry optimization: a quantitative study.
N. Trotta, Benoît Collette, C. Mathey, I. Vierasu +4 more
2022Medical Physics (Lancaster)4 citations Open access
Semantic Scholar
166Ho‐RadioEmbolizaTiOn Using personalized prediCtive dosimetry in patients with Hepatocellular carcinoma: A prospective, single‐centre study (RETOUCH)
Ana-Maria Bucalau, Benoît Collette, I. Tancredi, I. Vierasu +4 more
2024Liver international (Print)3 citations Open access
Semantic Scholar
Duodenal Hemorrhage Due to an Invasive Hepatocellular Carcinoma Controlled by Transarterial Embolization
Maxime Deforche, Ana-Maria Bucalau, I. Tancredi, F. Tannouri +1 more
2022Cureus3 citations Open access
Semantic Scholar
Patient and physician expectations regarding disease and treatment of advanced HCC: The prospective PERCEPTION1 study
J. Nault, Nanthara Sritharan, G. Verset, I. Borbath +18 more
2024JHEP Reports2 citations Open access
Semantic Scholar
BioPearl™ doxorubicin microspheres for unresectable HCC: a prospective, single-arm, multicenter study: BIOPEARL-ONE
G. Verset, R. Iezzi, I. Bargellini, Ana-Maria Bucalau +4 more
2024Future Oncology2 citations Open access
Semantic Scholar
Complete response of a hepatocellular carcinoma with complex macrovascular invasion after combined treatment with chemoembolization and immunotherapy: a case report.
Ana-Maria Bucalau, I. Tancredi, M. Pezzullo, A. Covas +1 more
2021Acta gastro-enterologica Belgica2 citations Open access
Semantic Scholar
Safety, tolerability and efficacy of transarterial chemoembolization using anthracyclines-loaded drug eluting microspheres for treatment of patients with unresectable hepatocellular carcinoma: Pooled analyses.
T. de Baére, Filipe Veloso Gomes, G. Verset, Gerardo Tovar-Felice +3 more
20212 citations
Semantic Scholar
RECIST v1.1 and irRECIST outcomes in advanced HCC treated with pembrolizumab (pembro).
J. Edeline, M. Karwal, A. Zhu, R. Finn +16 more
20202 citations
Semantic Scholar
[Lynch syndrome and microsatellite instability: a review].
F. Desselle, G. Verset, M. Polus, E. Louis +1 more
2012Revue Medicale de Liege2 citations
Semantic Scholar
A plain language summary of the CheckMate 9DW study: nivolumab in combination with ipilimumab for unresectable hepatocellular carcinoma (advanced liver cancer)
T. Yau, P. Galle, T. Decaens, B. Sangro +24 more
2026Future Oncology1 citations Open access
Semantic Scholar
Impact of scatter correction on personalized dosimetry in selective internal radiotherapy using 166Ho-PLLA: a single-center study including Monte-Carlo simulation, phantom and patient imaging
Benoît Collette, Marie Mannie-Corbisier, Ana-Maria Bucalau, N. Pauly +4 more
2024EJNMMI Physics1 citations Open access
Semantic Scholar
Personalized medicine in pancreatic cancer: the revolution has begun.
R. Maréchal, F. Puleo, A. Demols, G. Verset +1 more
2015Personalized Medicine1 citations
Semantic Scholar
Octreotide for advanced hepatocellular cancer revisited: Final data of a meta-analysis approach based on single patient data
G. Treiber, B. O'Neil, D. Dimitroulopoulos, C. Lersch +3 more
20081 citations
Semantic Scholar
Limited Added Prognostic Value of Choline PET/CT in Treatment-Naïve Hepatocellular Carcinoma
I. Vierasu, H. Levillain, M. Pezzullo, Jennifer Dhont +16 more
2026World Journal of Nuclear Medicine0 citations Open access
Semantic Scholar
Deep learning predicts sensitivity to atezolizumab-bevacizumab from digital slides of hepatocellular carcinoma
Qinghe Zeng, Christoph Klein, S. Caruso, P. Maillé +67 more
2023Journal of Hepatology0 citations
Semantic Scholar
SO-13 Pembrolizumab in patients with advanced hepatocellular carcinoma (aHCC) previously treated with sorafenib: Updated data from the open-label, phase 2 KEYNOTE-224 study
A. Vogel, J. Edeline, S. Ogasawara, M. Kudo +16 more
2022Annals of Oncology0 citations Open access
Semantic Scholar
Clinical Impact of 99mTc-MAA SPECT/CT-based Personalized Predictive Dosimetry in Selective Internal Radiotherapy: a Retrospective, Single-center Study for Unresectable HCC Patients
Ana-Maria Bucalau, Benoît Collette, I. Tancredi, M. Vouche +6 more
20210 citations Open access
Semantic Scholar

Frequent co-authors

Invite them to SciRah by sharing their profile.

Ana-Maria Bucalau×13
Invite
Ana-Maria Bucalau — researcher profile on SciRah
J. Van Laethem×10
Invite
J. Van Laethem — researcher profile on SciRah
A. Zhu×9
Invite
A. Zhu — researcher profile on SciRah
J. Edeline×9
Invite
J. Edeline — researcher profile on SciRah

×8

Invite

R. Finn — researcher profile on SciRah

Invite

S. Cattan — researcher profile on SciRah

Invite

C. Verslype — researcher profile on SciRah

Invite

A. Vogel — researcher profile on SciRah

Invite

S. Chan — researcher profile on SciRah

Invite

B. Daniele — researcher profile on SciRah

Invite

A. Siegel — researcher profile on SciRah

Invite

A. Cheng — researcher profile on SciRah